Antiestrogen therapy in recurrent ovarian cancer resulting in 28 months of stable disease: A case report and review of the literature

Hormonal therapy for adjuvant treatment of ovarian cancer may provide a low toxicity option in some patients with refractory disease. A 53 year-old patient with stage IIIC papillary serous ovarian cancer previously treated with multiple chemotherapy regimens with platinum-resistant disease was treat...

Full description

Bibliographic Details
Main Authors: Carter Jori, Fowler Jeffrey, Argenta Peter, Kothari Rajul, Shimp William
Format: Article
Language:English
Published: Institute of Oncology, Sremska Kamenica, Serbia 2010-01-01
Series:Archive of Oncology
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0354-7310/2010/0354-73101002032K.pdf